Nobel Prize for Scientist Professor Robert G. Edwards, Editor Emeritus of Reproductive BioMedicine Online

Cambridge, UK, 5 October 2010 – Elsevier congratulates Cambridge scientist and Editor Emeritus of Reproductive BioMedicine Online (RBMOnline), Robert G. Edwards, who has been awarded with the 2010 Nobel Prize in Medicine for the development of in-vitro fertilisation (IVF), a breakthrough that has helped millions of infertile couples worldwide to have children. Professor Edwards, 85, started working on IVF, a procedure in which egg cells are fertilised outside the body and implanted in the womb, in the 1950s.

Professor Edwards founded the journal Reproductive BioMedicine Online in 2000 and published it independently for 10 years. Having developed it and ensured its place amongst the leading journals in the field of Reproductive Medicine, he began handing over the reins for the journal in 2009, becoming Editor Emeritus of RBMOnline. In 2010 Elsevier became the Publisher of this innovative journal, which promises to develop from strength to strength under its guardianship. Professor Edwards also cofounded the first IVF clinic in the world, Bourn Hall, where embryologists and doctors who received training went on to establish clinics worldwide.

According a statement released by the Nobel Prize in Physiology or Medicine committee in Stockholm, Robert G. Edwards’s achievements have made it possible to treat infertility, a medical condition afflicting a large proportion of humanity - more than 10% of all couples… Approximately four million individuals have been born thanks to IVF... Today, Robert Edwards’ vision is a reality and brings joy to infertile people all over the world[1].

“We offer our heartfelt congratulations to Professor Edwards on this most distinguished recognition of his achievements in medicine. As the publisher of Reproductive Biomedicine Online, Elsevier is honoured to build on Professor Edwards’ legacy and many contributions to the medical literature,” said Glen Campbell, Executive Vice President, Global Medical Research Journals at Elsevier.

Martin Johnson, Professor of Reproductive Sciences at the University of Cambridge and Editor at RBMOnline, said, "As one of Bob’s first research students I'm naturally delighted that he has been awarded the Nobel Prize. Bob is delighted, as are all his friends, family, and work colleagues at the journal office of Reproductive BioMedicine Online”. “It is truly wonderful that such an engaging, warm and generous person, as well as a visionary in science, can be acknowledged in this way for all his many achievements. He was a man much ahead of his time not just in IVF, but in preimplantation genetic diagnosis, the derivation of embryonic stem cells and also for his publications and lectures on ethics in science and the role of regulation. He transformed the whole approach to research and care in reproductive medicine and gynecology,” he remarked.

The medicine award was the first of the 2010 Nobel Prizes to be announced. The prestigious awards were created by Swedish industrialist Alfred Nobel, and first handed out in 1901, five years after his death. Each award includes 10 million Swedish kronor (about £1 million), a diploma and the Nobel Prize medal.

# # #

About RBMOnline
Reproductive BioMedicine Online (http://www.rbmojournal.com/) covers the formation, growth and differentiation of the human embryo. It is intended to bring to public attention new research on biological and clinical research onhuman reproduction and the human embryo including relevant studies on animals. It is published by a group of scientists and clinicians working in these fields of study. Its audience comprises researchers, clinicians, practitioners, academics and patients.

It is an official publication of the American College of Embryology (ACE) www.embcol.org; The Global Chinese Association for Reproductive Medicine (GCARM) www.gcarm.com; the International Society for In Vitro Fertilization (ISIVF) www.isivf.com; the Mediterranean Society for Reproductive Medicine (MSRM) www.medreproduction.org; the Preimplantation Genetic Diagnosis International Society (PGDIS) www.pgdis.org; and the Turkish Society of Reproductive Medicine (TSRM) www.tsrm.org.tr.

About Elsevier
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Research Intelligence and ClinicalKey— and publishes over 2,500 journals, including The Lancet and Cell, and more than 35,000 book titles, including a number of iconic reference works. Elsevier is part of RELX Group, a world-leading provider of information and analytics for professional and business customers across industries. www.elsevier.com

Media Contact
Rachel Holdsworth
(+44) 01954-202789
Rachel@holdsworth-associates.co.uk